- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03090373
The Effect of Surface Acoustic Waves on the Prevention of Colonization in Longterm Indwelling Urinary Caatheters
The Effect of Surface Acoustic Waves on the Prevention of Bacterial Colonization in Longterm Indwelling Urinary Catheters
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a double blinded Randomized controoled trial of 30 days duration. The trial device is the Uroshield, SAW device which is an externally applied device attached to the external portion of the urinary catheter.
Subjects will be randomized to a control group and the treatment group. The control group will receive standard of care for the care of indwelling urinary catheters, while being attached to a sham UroShield device. The treatment group will receive the same standard of care treatment but will be attached to an active UroShield SAW device.
At baseline and again at 30 days, both the catheter and retained urine from the bladder will be evaluated for the number of live colonies. These numbers will be evaluated to see if there is a difference between the active and sham devices.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Elmsford, New York, United States, 07055
- NanoVibronix
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Currently being treated with an indwelling urinary catheter for at least 30 days.
- Ability to sign informed consent or have someone authorized to sign informed consent.
Exclusion Criteria:
- Currently being treated for an active Urinary Tract infection.
- Previous treatment with Surface Acoustic Waves.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Control Group
At catheter replacement subjects will have a sham UroShield device attached to the external portion of the catheter and have it activated for 30 days. Standard of care for the upkeep and cleanliness of the catheter will be adhered to. At both the baseline and at the conclusion of 30 days, the distal end of the catheter will be collected as well as a sample of retained urine from the bladder and these samples will be evaluated for bacterial colonization. |
The UroShield is an externally applied acoustic actuator which generates surface acoustic waves and transmits them along the length of the catheter.
The device does not come in direct contact with the subjects.
Other Names:
|
|
Active Comparator: Treatment Group
At catheter replacement subjects will have an active UroShield device attached to the external portion of the catheter and have it activated for 30 days. Standard of care for the upkeep and cleanliness of the catheter will be adhered to. At both the baseline and at the conclusion of 30 days, the distal end of the catheter will be collected as well as a sample of retained urine from the bladder and these samples will be evaluated for bacterial colonization. |
The UroShield is an externally applied acoustic actuator which generates surface acoustic waves and transmits them along the length of the catheter.
The device does not come in direct contact with the subjects.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bacterial Colonization
Time Frame: 30 days
|
Number of cultured colonies from both the Urinary Catheter and retained urine
|
30 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- US-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Tract Infections
-
GlaxoSmithKlineCompletedInfections, Urinary TractEgypt
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Iterum Therapeutics, International LimitedCompletedComplicated Urinary Tract InfectionsUnited States, Estonia, Hungary, Georgia, Latvia
-
Shandong Branden Med.Device Co.,LtdTerminatedUrinary Tract Infection | Urinary CathetersChina
-
Newcastle-upon-Tyne Hospitals NHS TrustCambridge University Hospitals NHS Foundation Trust; University of Southampton and other collaboratorsCompletedUrinary Tract Infections, RecurrentUnited Kingdom
-
Inmunotek S.L.CompletedUrinary Tract Infection BacterialSpain, United Kingdom
-
Lawson Health Research InstituteCompletedUrinary Tract InfectionCanada
-
National Institute of Diabetes and Digestive and...Completed
-
AbbottCompletedUrinary Tract Infections (UTIs)Pakistan
-
Hospital del Rio HortegaCompletedUrinary Tract Infection
Clinical Trials on UroShield
-
Lawson Health Research InstituteTerminatedUrinary Tract Infections | Neurogenic BladderCanada
-
University of MichiganNanovibronixCompletedQuality of Life | Catheter-Associated Urinary Tract InfectionUnited States
-
HaEmek Medical Center, IsraelWithdrawn
-
Shaare Zedek Medical CenterUnknownMechanical Ventilation ComplicationIsrael
-
Shaare Zedek Medical CenterCompletedMechanically Ventilated Patients